<DOC>
	<DOCNO>NCT01570517</DOCNO>
	<brief_summary>The purpose study evaluate safety potential benefit interatrial septal defect ( IASD ) System patient heart failure preserve ejection fraction .</brief_summary>
	<brief_title>Feasibility Trial DC Devices Interatrial Septal Device ( IASD ) System</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Clinical diagnosis HFpEF Ejection Fraction least 45 % Imaging hemodynamic evidence HFpEF History exercise intolerance Symptomatic despite optimal medical management Signed study specific inform consent History thromboembolic event Significant structural heart disease coronary artery disease Contraindicated study require medication Right ventricular dysfunction History great mild restrictive obstructive lung disease Life expectancy less one year noncardiovascular reason Known suspect allergy implant material Fertile woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>